| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 03/03/2011 | WO2011024110A2 Glucagon-like peptide-1 receptor (glp-1r) agonists for treating autoimmune disorders |
| 03/03/2011 | WO2011023812A1 Microsomal prostaglandin e synthase-1 (mpges1) inhibitors |
| 03/03/2011 | WO2011023081A1 5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors |
| 03/03/2011 | WO2010148223A3 Anti-vegf antibodies and their uses |
| 03/03/2011 | WO2010132561A8 New human rotavirus strains and vaccines |
| 03/03/2011 | WO2010123971A3 Hydrogels for combinatorial delivery of immune-modulating biomolecules |
| 03/03/2011 | WO2010123919A3 Piperidine inhibitors of janus kinase 3 |
| 03/03/2011 | US20110055942 Single domain TDF-related compounds and analogs thereof |
| 03/03/2011 | US20110054159 Rna interference mediating small rna molecules |
| 03/03/2011 | US20110054032 Dioxoanthracene sulphonate derivatives |
| 03/03/2011 | US20110054003 Antisense oligonucleotide modulation of stat3 expression |
| 03/03/2011 | US20110053987 Pyridinium and thiazolium conjugates including polyethylene glycols and methods of using the same |
| 03/03/2011 | US20110053985 Novel piperidine-4-carboxylic acid phenyl-alkyl-amide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/03/2011 | US20110053974 Carboxylic acid compound |
| 03/03/2011 | US20110053973 Compounds as tyrosine kinase modulators |
| 03/03/2011 | US20110053959 Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 03/03/2011 | US20110053958 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto |
| 03/03/2011 | US20110053954 Method of treatment and/or prevention of brain, spinal or nerve injury |
| 03/03/2011 | US20110053944 Substituted dihydropteridin-6-one derivatives, process for their preparation and their use as kinase inhibitors |
| 03/03/2011 | US20110053941 IDO Inhibitors |
| 03/03/2011 | US20110053939 Novel aromatic nitro compounds |
| 03/03/2011 | US20110053935 Fused pyridines active as inhibitors of c-met |
| 03/03/2011 | US20110053932 Protein Kinase Inhibitors and Methods for Using Thereof |
| 03/03/2011 | US20110053931 Quinoline compounds and methods of use |
| 03/03/2011 | US20110053896 Osmolytes for the treatment of allergic or viral respiratory diseases |
| 03/03/2011 | US20110053876 macrolides and their use |
| 03/03/2011 | US20110053840 Allele and isotope-specific intervention on mhc class ii molecules associated with autoimmune diseases by means of peptides |
| 03/03/2011 | US20110053831 Compositions and uses thereof for the treatment of acute respiratory distress syndrome (ards) and clinical disorders associated with therewith |
| 03/03/2011 | US20110052729 Pharmaceutical or nutraceutical composition |
| 03/03/2011 | US20110052716 Adjuvant Comprising Aluminum, Oligonucleotide and Polycation |
| 03/03/2011 | US20110052694 Use of cannabidiol prodrugs in topical and transdermal administration with microneedles |
| 03/03/2011 | US20110052644 Composition comprising extract of cinnamomum cassia bark for improving normal flora and enhancing immune response |
| 03/03/2011 | US20110052643 Compounds for inflammation and immune-related uses |
| 03/03/2011 | US20110052642 Peripheral zone tumor cells, methods for their preparation and use |
| 03/03/2011 | US20110052639 Allergen mutants |
| 03/03/2011 | US20110052638 Allergens from aspergillus versicolor, and method of detecting a mold allergy caused by interior rooms |
| 03/03/2011 | US20110052632 Hiv polynucleotides and polypeptides derived from botswana mj4 |
| 03/03/2011 | US20110052631 Induction of proliferation, effector molecule expression, and cytolytic capacity of hiv-specific cd8+ t cells |
| 03/03/2011 | US20110052630 Compositions and Methods Using Herpes Simplex Virus |
| 03/03/2011 | US20110052629 Methods of reducing concomitant infections in pigs with a pcv2 antigen |
| 03/03/2011 | US20110052627 Recombinant modified vaccinia virus measles vaccine |
| 03/03/2011 | US20110052618 Influenza hemagglutinin and neuraminidase variants |
| 03/03/2011 | US20110052616 Biological materials and uses thereof |
| 03/03/2011 | US20110052615 Tumour-specific animal proteins |
| 03/03/2011 | US20110052614 Stat3 epitope peptides |
| 03/03/2011 | US20110052613 Method for the treatment of neurological disorders by enhancing the activity of beta-glucocerebrosidase |
| 03/03/2011 | US20110052612 Spiropiperidine compound and medicinal use thereof |
| 03/03/2011 | US20110052610 Antibody composition exhibiting cellular cytotoxicty due to glycosylation |
| 03/03/2011 | US20110052606 Humanized Anti-Human NKG2A Monoclonal Antibody |
| 03/03/2011 | US20110052603 method of treatment and agents useful for same |
| 03/03/2011 | US20110052600 Il-17ra-il-17rb antagonists and uses thereof |
| 03/03/2011 | US20110052598 Method for screening of therapeutic agent for allergic airway inflammation and/or airway hypersensitivity using il-17rb-positive nkt cell |
| 03/03/2011 | US20110052596 Antibodies to il-17a |
| 03/03/2011 | US20110052590 Neutrokine-alpha antibodies and methods of use thereof |
| 03/03/2011 | US20110052587 Peptide or protein comprising a c'-d loop of the cd28 receptor family |
| 03/03/2011 | US20110052584 Method of enhancement of cytotoxicity in antibody mediated immune responses |
| 03/03/2011 | US20110052578 Compounds and Compositions as Protein Kinase Inhibitors |
| 03/03/2011 | US20110052571 Method for treating idiopathic thrombocytopenic purpura using monoclonal antibodies |
| 03/03/2011 | US20110052564 Enhancement of immunogenicity of antigens |
| 03/03/2011 | US20110052560 Method for Increasing the Activity of the Immune System of a Mammal at Risk of Inflammatory Diseases |
| 03/03/2011 | US20110052554 Methods for off-the- shelf tumor immunotherapy using allogeneic t-cell precursors |
| 03/03/2011 | US20110052553 Strain of lactobacillus plantarum lp28 and its use in treating hypersensitivity reactions |
| 03/03/2011 | US20110052550 Therapeutic Uses of Allogeneic Myeloid Progenitor Cells |
| 03/03/2011 | US20110052535 Compositions for treating an inflammatory autoimmune condition |
| 03/03/2011 | US20110052532 Pharmaceutical composition comprising a cytokine |
| 03/03/2011 | US20110052525 Breaking Immunological Tolerance with a Genetically Encoded Unnatural Amino Acid |
| 03/03/2011 | US20110052501 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics |
| 03/03/2011 | US20110052493 Use of polypeptides obtained through systematic mutations of single amino acids of human and non-human box-a of hmgb1 to prevent and/or antagonize pathologies induced by hmgb1 |
| 03/03/2011 | US20110052489 Anti-CD19 Antibodies |
| 03/03/2011 | US20110052488 Methods For Treating, Diagnosing, and Monitoring Rheumatoid Arthritis |
| 03/03/2011 | DE102009037089A1 Zusammensetzung mit Stämmen von Lactobazillus fermentum Composition with Lactobacillus fermentum strains of |
| 03/03/2011 | CA2808867A1 Methods for treating conditions mediated by the inflammatory cytokine cascade using gapdh inhibitors |
| 03/03/2011 | CA2772551A1 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
| 03/03/2011 | CA2771781A1 Antikine antibodies that bind to multiple cc chemokines |
| 03/03/2011 | CA2771215A1 Therapeutic preparation for rhinitis |
| 03/03/2011 | CA2769835A1 Glucagon-like peptide-1 receptor (glp-1r) agonists for treating autoimmune disorders |
| 03/03/2011 | CA2769151A1 5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors |
| 03/02/2011 | EP2290079A2 Neurotrophic factors |
| 03/02/2011 | EP2289941A2 Administration of agents for the treatment of inflammation |
| 03/02/2011 | EP2289911A2 Therapeutic use of a growth factor, NsG33 |
| 03/02/2011 | EP2289894A2 Pyrrolo-triazine compounds useful as kinase inhibitors |
| 03/02/2011 | EP2289559A1 Anit-CD70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
| 03/02/2011 | EP2289551A1 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 03/02/2011 | EP2289549A2 Immunoconjugates for treating cancer |
| 03/02/2011 | EP2289534A1 Modulation of NKG2D |
| 03/02/2011 | EP2289499A2 Methods and compositions for prevention and treatment of inflammatory disease, autoimmune disease, and transplant rejection |
| 03/02/2011 | EP2289488A2 Remedies for diseases to be applied to eye |
| 03/02/2011 | EP2288702A1 Combination therapies against cancer |
| 03/02/2011 | EP2288621A2 Il-23 receptor antagonists and uses thereof |
| 03/02/2011 | EP2288414A1 Anhydrous and hydrate forms of crystalline 2- ( (2s, 3r, 4e, 6e, 1oe, 12s) -13- (4-fluorophenoxy) -2,3, 12- (trihydroxytrideca-4, 6, 10-trien-8-ynyl) oxy) acetic acid |
| 03/02/2011 | EP2288372A2 Means for the treatment and/or prophylaxis of an autoimmune disease and for the formation of regulatory t-cells |
| 03/02/2011 | EP2288361A1 Cistus extract containing enriched secondary plant ingredients |
| 03/02/2011 | EP2288359A1 Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents |
| 03/02/2011 | EP2288348A1 Nanoparticles functionalized with sulfated amino alcohols for the inhibition of selectin-mediated cell adhesion |
| 03/02/2011 | EP2288337A1 Parenteral supplement with traceelem ntsfor treatment of i. a. sirs, burns selenium-defenciencies |
| 03/02/2011 | EP2137181B1 Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate (s1p) agonists |
| 03/02/2011 | EP1957481B1 Pyrrolidin(thi)ones heterocyclically substituted in 3-position |
| 03/02/2011 | EP1656131B1 Use of betaine for treating intermittent claudication |
| 03/02/2011 | EP1650225B1 Hetero type pentamer recombinant vaccine |
| 03/02/2011 | EP1646656B1 Human antibody molecules for il-13 |